Biomarkers Improve Clinical Outcome Predictors of Mortality Following Non-Penetrating Severe Traumatic Brain Injury

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

(2015) Linda Papa et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

End-tidal carbon dioxide is associated with mortality and lactate in patients with suspected sepsis

(2012) Christopher L. Hunter et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury

(2012) Stefania Mondello et al.   BRAIN INJURY

Brain Injury Biomarkers May Improve the Predictive Power of the IMPACT Outcome Calculator

(2012) Endre Czeiter et al.   JOURNAL OF NEUROTRAUMA

106 Neuronal Biomarkers May Require Age-Adjusted Norms

(2011) I. Ferguson et al.   ANNALS OF EMERGENCY MEDICINE

Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids

(2011) Gretchen M. Brophy et al.   JOURNAL OF NEUROTRAUMA

Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and αII-Spectrin Breakdown Product 145 kDa Correlate with Outcome after Pediatric TBI

(2011) Rachel P. Berger et al.   JOURNAL OF NEUROTRAUMA

Large Between-Center Differences in Outcome After Moderate and Severe Traumatic Brain Injury in the International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury (IMPACT) Study

(2011) Hester F. Lingsma et al.   NEUROSURGERY

Protein Biomarkers for Traumatic and Ischemic Brain Injury: From Bench to Bedside

(2011) Zhiqun Zhang et al.   Translational Stroke Research

Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats

(2010) Ming C. Liu et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

The Epidemiology of Traumatic Brain Injury

(2010) John D. Corrigan et al.   JOURNAL OF HEAD TRAUMA REHABILITATION

αII-Spectrin Breakdown Products (SBDPs): Diagnosis and Outcome in Severe Traumatic Brain Injury Patients

(2010) Stefania Mondello et al.   JOURNAL OF NEUROTRAUMA

Compression Alters Kinase and Phosphatase Activity and Tau and MAP2 Phosphorylation Transiently while Inducing the Fast Adaptive Dendritic Remodeling of Underlying Cortical Neurons

(2010) Li-Jin Chen et al.   JOURNAL OF NEUROTRAUMA

GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study

(2010) P. E. Vos et al.   NEUROLOGY

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*

(2009) Linda Papa et al.   CRITICAL CARE MEDICINE

Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by Contusion

(2009) Melissa J. McGinn et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

αII-Spectrin Breakdown Product Cerebrospinal Fluid Exposure Metrics Suggest Differences in Cellular Injury Mechanisms after Severe Traumatic Brain Injury

(2009) Gretchen M. Brophy et al.   JOURNAL OF NEUROTRAUMA

A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans

(2009) Robert Siman et al.   JOURNAL OF NEUROTRAUMA

Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients

(2008)   BMJ-British Medical Journal

Predicting Outcome after Traumatic Brain Injury: Development and International Validation of Prognostic Scores Based on Admission Characteristics

(2008) Ewout W Steyerberg et al.   PLOS MEDICINE